JP2024520556A - 新規遺伝子サイレンシング技術としての短鎖二重鎖dnaおよびその使用 - Google Patents
新規遺伝子サイレンシング技術としての短鎖二重鎖dnaおよびその使用 Download PDFInfo
- Publication number
- JP2024520556A JP2024520556A JP2023573589A JP2023573589A JP2024520556A JP 2024520556 A JP2024520556 A JP 2024520556A JP 2023573589 A JP2023573589 A JP 2023573589A JP 2023573589 A JP2023573589 A JP 2023573589A JP 2024520556 A JP2024520556 A JP 2024520556A
- Authority
- JP
- Japan
- Prior art keywords
- sddna
- molecule
- strand
- modified
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/335—Modified T or U
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/50—Methods for regulating/modulating their activity
- C12N2320/53—Methods for regulating/modulating their activity reducing unwanted side-effects
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195010P | 2021-05-29 | 2021-05-29 | |
| US63/195,010 | 2021-05-29 | ||
| PCT/US2022/031666 WO2022256354A1 (en) | 2021-05-29 | 2022-05-31 | Short duplex dna as a novel gene silencing technology and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520556A true JP2024520556A (ja) | 2024-05-24 |
| JP2024520556A5 JP2024520556A5 (cg-RX-API-DMAC10.html) | 2025-06-10 |
Family
ID=82358463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023573589A Pending JP2024520556A (ja) | 2021-05-29 | 2022-05-31 | 新規遺伝子サイレンシング技術としての短鎖二重鎖dnaおよびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240254490A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4347828A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024520556A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240014533A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118369428A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022286925A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3221923A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202313977A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022256354A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024298074A1 (en) * | 2023-07-21 | 2026-02-19 | Bisirna Therapeutics Pte. Ltd. | Double-stranded oligonucleotide agents and uses thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010504750A (ja) * | 2006-09-27 | 2010-02-18 | コーリー ファーマシューティカル ゲーエムベーハー | 増強された免疫刺激活性を有する疎水性T類似体を含有するCpGオリゴヌクレオチド類似体 |
| WO2017068790A1 (ja) * | 2015-10-23 | 2017-04-27 | レナセラピューティクス株式会社 | 核酸複合体 |
| WO2018062510A1 (ja) * | 2016-09-29 | 2018-04-05 | 国立大学法人東京医科歯科大学 | オーバーハングを有する二本鎖核酸複合体 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100523215C (zh) | 2000-12-01 | 2009-08-05 | 马普科技促进协会 | 介导rna干涉的小rna分子 |
| US7074824B2 (en) | 2001-07-31 | 2006-07-11 | Arqule, Inc. | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| US6962944B2 (en) | 2001-07-31 | 2005-11-08 | Arqule, Inc. | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| CA2504694C (en) | 2002-11-05 | 2013-10-01 | Isis Pharmaceuticals, Inc. | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| DK1661905T3 (da) | 2003-08-28 | 2012-07-23 | Takeshi Imanishi | Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype |
| WO2005027962A1 (en) | 2003-09-18 | 2005-03-31 | Isis Pharmaceuticals, Inc. | 4’-thionucleosides and oligomeric compounds |
| EP1799859B1 (en) | 2004-09-17 | 2014-07-02 | Isis Pharmaceuticals, Inc. | Enhanced antisense oligonucleotides |
| DE602007009487D1 (de) | 2006-01-27 | 2010-11-11 | Isis Pharmaceutical Inc | 6-modifizierte bicyclische nukleinsäureanaloga |
| EP2505646A1 (en) | 2006-05-05 | 2012-10-03 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression of CRP |
| CA2651453C (en) | 2006-05-11 | 2014-10-14 | Isis Pharmaceuticals, Inc. | 5'-modified bicyclic nucleic acid analogs |
| US20100190837A1 (en) | 2007-02-15 | 2010-07-29 | Isis Pharmaceuticals, Inc. | 5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom |
| DK2170917T3 (da) | 2007-05-30 | 2012-10-08 | Isis Pharmaceuticals Inc | N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro |
| WO2008154401A2 (en) | 2007-06-08 | 2008-12-18 | Isis Pharmaceuticals, Inc. | Carbocyclic bicyclic nucleic acid analogs |
| AU2008272918B2 (en) | 2007-07-05 | 2012-09-13 | Isis Pharmaceuticals, Inc. | 6-disubstituted bicyclic nucleic acid analogs |
| EP3121281B1 (en) | 2007-08-27 | 2021-03-31 | 1Globe Health Institute LLC | Compositions of asymmetric interfering rna and uses thereof |
| JP6472087B2 (ja) * | 2013-05-30 | 2019-02-27 | 国立大学法人 東京医科歯科大学 | 治療用オリゴヌクレオチドを送達するための二本鎖剤 |
-
2022
- 2022-05-31 AU AU2022286925A patent/AU2022286925A1/en active Pending
- 2022-05-31 JP JP2023573589A patent/JP2024520556A/ja active Pending
- 2022-05-31 US US18/564,602 patent/US20240254490A1/en active Pending
- 2022-05-31 CA CA3221923A patent/CA3221923A1/en active Pending
- 2022-05-31 CN CN202280038744.5A patent/CN118369428A/zh active Pending
- 2022-05-31 KR KR1020237045355A patent/KR20240014533A/ko active Pending
- 2022-05-31 EP EP22736074.0A patent/EP4347828A1/en active Pending
- 2022-05-31 WO PCT/US2022/031666 patent/WO2022256354A1/en not_active Ceased
- 2022-06-14 TW TW111122093A patent/TW202313977A/zh unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010504750A (ja) * | 2006-09-27 | 2010-02-18 | コーリー ファーマシューティカル ゲーエムベーハー | 増強された免疫刺激活性を有する疎水性T類似体を含有するCpGオリゴヌクレオチド類似体 |
| WO2017068790A1 (ja) * | 2015-10-23 | 2017-04-27 | レナセラピューティクス株式会社 | 核酸複合体 |
| WO2018062510A1 (ja) * | 2016-09-29 | 2018-04-05 | 国立大学法人東京医科歯科大学 | オーバーハングを有する二本鎖核酸複合体 |
Non-Patent Citations (1)
| Title |
|---|
| "Design of 2'-O-methyl RNA and DNA double-stranded oligonucleotides: naturally-occurring nucleotide c", NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS , vol. Vol. 39, No. 1-3, JPN7026002434, 11 September 2019 (2019-09-11), pages 292 - 309, ISSN: 0005875158 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118369428A (zh) | 2024-07-19 |
| AU2022286925A1 (en) | 2023-12-21 |
| WO2022256354A1 (en) | 2022-12-08 |
| EP4347828A1 (en) | 2024-04-10 |
| US20240254490A1 (en) | 2024-08-01 |
| TW202313977A (zh) | 2023-04-01 |
| KR20240014533A (ko) | 2024-02-01 |
| CA3221923A1 (en) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020257111B2 (en) | RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy | |
| JP5876637B2 (ja) | ニックまたはギャップの入った核酸分子およびそれらの使用 | |
| JP2022071053A (ja) | 筋強直性ジストロフィープロテインキナーゼ(dmpk)の発現を調節するための化合物及び方法 | |
| WO2014192310A1 (en) | Double-stranded agents for delivering therapeutic oligonucleotides | |
| KR20240043822A (ko) | 올리고뉴클레오티드 제제를 위한 올리고뉴클레오티드 기반 전달체 및 이의 사용 방법 | |
| JP2024520555A (ja) | 新規遺伝子サイレンシング技術としての非対称短鎖二重鎖dnaおよびその使用 | |
| JP2025542580A (ja) | 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している短鎖二重鎖rna、およびその使用 | |
| US20240254490A1 (en) | Short Duplex DNA as a Novel Gene Silencing Technology and Use Thereof | |
| JP2025542579A (ja) | 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している非対称短鎖二重鎖rna、およびその使用 | |
| JP7208911B2 (ja) | 核酸分子発現の調節 | |
| JP2025542581A (ja) | アンチセンスRNA(asRNA)技術およびその使用 | |
| HK40108297A (en) | Short duplex dna as a novel gene silencing technology and use thereof | |
| HK40110327A (en) | Asymmetric short duplex dna as a novel gene silencing technology and use thereof | |
| HK40078359A (en) | Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250602 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250602 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20260423 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260602 |